Nebenwirkungen · Giotrif
GIOTRIF 20 mg film-coated tablets GIOTRIF 30 mg film-coated tablets GIOTRIF 40 mg film-coated tablets GIOTRIF 50 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8
HOS-214114 · Präparat HOS-155264
Tabulated list of adverse reactions Table 2 summarises the frequencies of ADRs from all NSCLC trials and from post-marketing experience with daily GIOTRIF doses of 40 mg or 50 mg as monotherapy. The following terms are used to rank the ADRs by frequency: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1 000 to < 1/100); rare (≥ 1/10 000 to < 1/1 000); very rare (< 1/10 000). Within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-11T16:31:00Z · SHA-256 f9bce1a1b6cb4de0c103c283912dbcf5714eff2cc72ce93f25eb6c1e97fd88eb · Passage 4403503d5e4762ea55561dff363f8410d7ec9f4683b9732ad2b63a252085defa · Zeichen 1090–1583 im Abschnitt